SCHEMBL31243350

SCHEMBL31243350

C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(N)=O)NC(=O)CN)[C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ NPY1R P25929 1/20 0.63
▸ NPY2R P49146 1/20 0.63
▸ NPY4R P50391 1/20 0.63
▸ NPY5R Q15761 1/20 0.63
▸ CXCR4 P61073 4/20 0.60
▸ MC4R P32245 2/20 0.57
▸ MC5R P33032 2/20 0.57
▸ MC3R P41968 2/20 0.57
▸ MC1R Q01726 2/20 0.57
▸ IL23R Q5VWK5 2/20 0.57
▸ GLP1R P43220 8/20 0.57
▸ CALCA P06881 1/20 0.56
▸ GNRHR P30968 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30429251 0.87 CALCA (0.62) NPY1RNPY2RNPY4RNPY5RCXCR4
SCHEMBL29992945 0.85 CALCA (0.59) NPY1RNPY2RNPY4RNPY5RCXCR4
SCHEMBL30973980 0.85 DPP3 (0.58) CXCR4
SCHEMBL30974317 0.84 DPP3 (0.58) CXCR4
SCHEMBL31410847 0.84 CXCR4 (0.66) NPY1RNPY2RNPY4RNPY5RCXCR4
SCHEMBL29379403 0.83 CCKBR (0.59) MC4RMC5RMC3RMC1RIL23R
SCHEMBL29496930 0.82 NPY1R (0.62) NPY1RNPY2RNPY4RNPY5RCXCR4
SCHEMBL22807694 0.82 NPY1R (0.62) NPY1RNPY2RNPY4RNPY5RCXCR4
SCHEMBL29461565 0.81 IL23R (0.63) NPY1RNPY2RNPY4RNPY5RCXCR4
SCHEMBL30256961 0.81 CXCR4 (0.59) NPY1RNPY2RNPY4RNPY5RCXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4713094-A2 PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF HEARING LOSS Pharmazz, Inc. (US) 2026-03-25 — — EP disclosed
WO-2024238297-A2 PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF HEARING LOSS PHARMAZZ, INC. (US) 2024-11-21 — — WO disclosed
US-20240382461-A1 PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION AND TREATMENT OF HEARING LOSS PHARMAZZ, INC. (US) 2024-11-21 — — US disclosed
Send feedback